Statements (37)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
fluoroquinolone |
| gptkbp:approvedBy |
1985
|
| gptkbp:ATCCode |
J01MA01
|
| gptkbp:brand |
Floxin
Oflox Tarivid |
| gptkbp:CASNumber |
82419-36-1
|
| gptkbp:contraindication |
children
pregnancy hypersensitivity to quinolones |
| gptkbp:discoveredBy |
gptkb:Daiichi_Sankyo
|
| gptkbp:eliminationHalfLife |
4-5 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:hasMolecularFormula |
C18H20FN3O4
|
| https://www.w3.org/2000/01/rdf-schema#label |
ofloxacin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits DNA gyrase
inhibits topoisomerase IV |
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
topical intravenous |
| gptkbp:sideEffect |
nausea
diarrhea dizziness headache insomnia |
| gptkbp:usedFor |
gptkb:prostatitis
skin infections urinary tract infections gonorrhea bacterial infections respiratory tract infections |
| gptkbp:bfsParent |
gptkb:Fluoroquinolones
|
| gptkbp:bfsLayer |
5
|